AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Viral Hepatitis

Califf, FDA top officials call for sweeping review of agency opioids policies

FDA

Editor’s Note: Reducing opioid misuse not only reduces deaths from overdose but is also key to reducing new HIV and viral hepatitis infections among persons who inject drugs. For more on the link between opioid misuse, HIV and viral hepatitis, see this CDC report. In response to the opioid abuse epidemic, today Dr. Robert Califf, the…

Register Today for Webinar on Viral Hepatitis: Opportunities for Faith-based Groups

hv_map

The HHS Center for Faith-based and Neighborhood Partnerships (Partnership Center) and the Office of HIV/AIDS and Infectious Disease Policy (OHAIDP) have re-scheduled their co-sponsored webinar on the important role of faith communities in the national response to viral hepatitis.  The webinar will introduce a new resource for faith-based groups, the Health Ministers Guide to Viral Hepatitis:…

Justice Department Settles with Alabama Moving Company Over Hepatitis-C Discrimination

Department of Justice seal

The Justice Department reached an agreement today with Kemper Moving Systems Inc., a Huntsville, Alabama, franchise of Two Men and a Truck, to resolve allegations that the moving company violated the Americans with Disabilities Act (ADA) when it refused service because of a customer’s Hepatitis-C. Under the terms of a two-year consent decree filed today…

FDA approves Zepatier for treatment of chronic hepatitis C genotypes 1 and 4

FDA

The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. Hepatitis C is a viral disease that causes inflammation of the liver that can lead to diminished liver function or liver failure….

Register Today for Webinar on Viral Hepatitis: Opportunities for Faith-based Groups

hv_map

NOTE: This webinar has been postponed. Watch this blog for an update on the new date and time. The HHS Center for Faith-based and Neighborhood Partnerships (Partnership Center) and the Office of HIV/AIDS and Infectious Disease Policy (OHAIDP) are co-sponsoring a webinar before the open enrollment period for 2016 coverage from the Health Insurance Marketplace closes…

ICYMI – HHS Seeks Info on Non-Federal Efforts to Address Viral Hepatitis in the U.S.

fcdcb3b1-a07b-4898-8583-467d033f62d2

Last month, HHS published a Request for Information (RFI) seeking information on non-Federal activities that support the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis. Non-federal stakeholders play a vital role in achieving our national goals for viral hepatitis prevention, diagnosis, care and treatment. Information collected in response to this RFI will…

Updated Expert Guidance on the Management of Chronic Hepatitis B Now Available

aasld-primary-logo-resized

In November 2015, the American Association for the Study of Liver Diseases (AASLD) released updated guidelines for the treatment of chronic hepatitis B infection. Developed and disseminated by AASLD, a professional society of scientists and health care professionals committed to preventing and curing liver disease, the new guidelines are an important tool to support clinical…

Slides Now Available! 2015 APHA Special Session: The Changing Epidemiology of Viral Hepatitis – Hepatitis C Emerging Trends and Disparities

apha-logo

In November at the 143rd American Public Health Association (APHA) Annual Meeting & Exposition, OHAIDP facilitated a special session, “The Changing Epidemiology of Viral Hepatitis – Hepatitis C Emerging Trends and Disparities.” Michelle Moses-Eisenstein, MPH, the session organizer and moderator, opened the 90-minute Special Epidemiology session and introduced the speakers. Scott Holmberg, MD, MPH, Chief,…